Loss of CYP27B1 expression and molecular defects may lead to reduced VDR signaling and correlate with disease progression and recurrence in many types of solid tumors such as breast cancer and non-melanoma skin cancer (Nemazannikova et al., 2019; Voutsadakis, 2020). This evidence concerns the gene VDR and breast cancer.